• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    GenMark Diagnostics, Inc. (GNMK)

    13.29 Mar 27, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    GenMark Diagnostics, Inc.
    5964 La Place Court
    Carlsbad, CA 92008
    United States - Map
    Phone: 760-448-4300
    Fax: 760-448-4301
    Website: http://www.genmarkdx.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:195

    Business Summary 

    GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company’s products include XT-8 system, an automated molecular diagnostic system that enables reference laboratories and hospitals to perform molecular diagnostic tests. The company offers eight diagnostic tests for use with its XT-8 system that includes Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test, Respiratory Viral Panel, hepatitis C virus, genotyping tests, a 3A4/3A5 genotyping test, and a 2C19 genotyping test. It also provides ePlex system, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using the ePlex system to place the patient sample into the test cartridge and obtain results without any additional steps. Genmark Diagnostics, Inc. is headquartered in Carlsbad, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GenMark Diagnostics, Inc.

    Corporate Governance 
    GenMark Diagnostics, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 8. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 8; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Hany Massarany , 54
    Chief Exec. Officer, Pres and Director
    Ms. Jennifer Williams , 42
    Sr. VP of HR
    Mr. Michael Gleeson , 40
    Sr. VP of North American Commercial Operations
    Mr. Ingo Chakravarty , 47
    Sr. VP of International
    Dr. Jon Faiz Kayyem Ph.D., 51
    Founder and Sr. VP of R&D
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders